Skip to main content
Livermore
Livermore
ZHEN

C4 Therapeutics, Inc.

CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662579

No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding C4 Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CCCC: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1181113−4
Shares64.2M3564.4M+219.7K (+0.3%)
Value$365.9M$200$231.8M−$134.0M (−36.6%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held C4 Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CCCC in Q4 2024
InstitutionSharesValue% of portfolio
Samlyn Capital, LLC3,019,458$10.9M0.17%
Sio Capital Management, LLC155,000$558.0K0.16%
Susquehanna Fundamental Investments, LLC108,664$391.2K0.01%
Atom Investors LP101,684$366.1K0.05%
Verition Fund Management LLC69,628$250.7K0.00%
ExodusPoint Capital Management, LP59,654$215.0K0.00%
Walleye Capital LLC40,819$146.9K0.00%
Intrepid Family Office LLC40,000$144.0K0.15%
Group One Trading, L.P.32,883$118.4K0.00%
Y-Intercept (Hong Kong) Ltd23,176$83.4K0.01%
Lazard Asset Management LLC22,693$81.0K0.00%
Delta Investment Management, LLC20,000$72.0K0.01%
China Universal Asset Management Co., Ltd.14,967$53.9K0.01%
Kazazian Asset Management, LLC14,250$51.3K0.04%
SEI Investments Co12,399$44.6K0.00%
Police & Firemen's Retirement System of New Jersey11,788$42.4K0.00%
BNP Paribas Arbitrage, SA6,742$24.3K0.00%
R Squared Ltd3,310$11.9K0.01%
Skopos Labs, Inc.3,033$10.9K0.00%
Mirae Asset Global Investments Co., Ltd.2,352$8.91K0.00%
GF Fund Management Co. Ltd.1,482$5.33K0.00%
SBI Securities Co., Ltd.150$5400.00%
CoreCap Advisors, LLC128$4610.00%
Caitong International Asset Management Co., Ltd15$540.00%
EverSource Wealth Advisors, LLC4$140.00%

Sold out (29)

Institutions that held C4 Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CCCC in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Commodore Capital LP3,410,384$19.4M
Trexquant Investment LP266,159$1.52M
Squarepoint Ops LLC147,874$842.9K
Rafferty Asset Management, LLC143,855$820.0K
BIT Capital GmbH138,899$791.7K
Jump Financial, LLC134,636$767.4K
XTX Topco Ltd84,951$484.2K
Arete Wealth Advisors, LLC73,350$418.0K
TD Asset Management Inc43,400$255.6K
Hussman Strategic Advisors, Inc.42,000$239.4K
Deutsche Bank AG39,180$223.3K
Vestcor Inc29,500$168.0K
Profund Advisors LLC28,436$162.1K
SG Americas Securities, LLC24,941$142.0K
Gsa Capital Partners LLP15,446$88.0K
Aigen Investment Management, LP14,344$81.8K
Prudential Financial Inc12,025$68.5K
Cornercap Investment Counsel Inc11,791$67.2K
Ameriprise Financial Inc11,620$66.2K
Cynosure Management, LLC10,007$57.0K
Morgan Dempsey Capital Management LLC1,500$8.55K
CWM, LLC1,018$6.00K
Advisor Group Holdings, Inc.530$3.02K
GAMMA Investing LLC217$1.24K
Clear Street Markets LLC143$1.00K
Nisa Investment Advisors, LLC165$941
Lindbrook Capital, LLC100$570
Cape Investment Advisory, Inc.100$570
Capital Performance Advisors LLP54$308

Not filed for Q4 2024 yet (1)

Institutions that held C4 Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CCCC in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Planning Capital Management Corp35$200